Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026

Rhea-AI Summary

Caris Life Sciences (NASDAQ: CAI) announced it will report first quarter 2026 financial results on Thursday, May 7, 2026. A live webcast will begin at 3:30 p.m. CT (4:30 p.m. ET) to discuss results, with a replay posted on the company investor relations website shortly after the call.

News Market Reaction – CAI

+0.43%

4 alerts

+0.43% Session close to close

$6.26B Market Cap

0.1x Rel. Volume

In the Apr 20 session, CAI gained 0.43%, reflecting a mild positive market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timeline for first-quarter 2026 results on May 7, 2026, with a webcast at...

Analysis

This announcement sets the timeline for first-quarter 2026 results on May 7, 2026, with a webcast at 3:30 p.m. CT. Historically, the only tagged earnings-date release saw a modest +1.41% move, suggesting limited but positive anticipation. Investors may watch how these results intersect with recent product launches, AI initiatives, and the new credit agreement detailed in recent SEC filings.

Key Figures

Earnings release date: May 7, 2026 Webcast time (CT): 3:30 p.m. CT Webcast time (ET): 4:30 p.m. ET +1 more

4 metrics

Earnings release date May 7, 2026 Scheduled first quarter 2026 financial results

Webcast time (CT) 3:30 p.m. CT Scheduled earnings webcast start time

Webcast time (ET) 4:30 p.m. ET Corresponding Eastern Time for webcast

Publication date April 20, 2026 Earnings date announcement release

Previous Earnings date Reports

1 past event · Latest: Feb 09 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 09	Earnings call scheduled	Neutral	+1.4%	Announced date and webcast details for Q4 and full-year 2025 results.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings date news saw a modest positive move of 1.41%, consistent with today’s pre-earnings uptick.

Recent Company History

Over recent months Caris Life Sciences has reported multiple product and AI-related advances, with several announcements followed by positive price reactions, including the Achieve 1 study results and new AI insights. For the specific earnings date tag, a prior event on Feb 09, 2026 saw a 1.41% gain after scheduling the Q4 and full-year 2025 results call, suggesting mildly constructive positioning into earnings dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

IRVING, Texas, April 20, 2026 /PRNewswire/ -- Caris Life Sciences^® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced it will report first quarter 2026 financial results on Thursday, May 7, 2026.

Caris Life Sciences will host a live webcast at 3:30 p.m. CT (4:30 p.m. ET) to discuss the financial results.

Webcast Details:

Date: Thursday, May 7, 2026
Time: 3:30 p.m. CT (4:30 p.m. ET)
Live Webcast: https://edge.media-server.com/mmc/p/6iwr2xf8/

A replay of the webcast will be available shortly after the conclusion of the call on the Investor Relations section of the Caris Life Sciences website at CarisLifeSciences.com.

About Caris Life Sciences 
Caris Life Sciences^® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Genome, Whole Exome and Whole Transcriptome Sequencing), advanced AI and machine learning, Caris has created the large-scale, multimodal clinico-genomic database and computing capability needed to analyze and further unravel the molecular complexity of disease. This convergence of next-generation sequencing, AI and machine learning technologies and high-performance computing provides a differentiated platform for developing the latest generation of advanced precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection and drug development. 

Caris was founded with a vision to realize the potential of precision medicine to improve the human condition. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S. and other international markets. 

Caris Life Sciences Media:
Corporate Communications
CorpComm@CarisLS.com
214.294.5606

Investor Relations:
IR@CarisLS.com
917.689.3511

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/caris-life-sciences-to-report-first-quarter-2026-financial-results-on-may-7-2026-302746471.html

SOURCE Caris Life Sciences

FAQ

When will Caris Life Sciences (CAI) report Q1 2026 results?

Caris will report Q1 2026 financial results on Thursday, May 7, 2026 at 3:30 p.m. CT. According to the company, management will discuss results during a live webcast that starts at 3:30 p.m. CT (4:30 p.m. ET) and a replay will be posted online.

What time is the Caris Life Sciences (CAI) webcast for Q1 2026 earnings?

The live webcast is scheduled for 3:30 p.m. CT (4:30 p.m. ET) on May 7, 2026. According to the company, the webcast will discuss first quarter financial results and a replay will be made available on the investor relations section of the company website.

Where can investors watch the Caris Life Sciences (CAI) Q1 2026 webcast?

Investors can watch the live webcast via the company's provided streaming link on May 7, 2026 at 3:30 p.m. CT. According to the company, a replay of the webcast will be available shortly after the call on the investor relations page at CarisLifeSciences.com.

Will a replay of the Caris Life Sciences (CAI) May 7, 2026 webcast be available?

Yes, a replay will be available shortly after the conclusion of the May 7, 2026 webcast. According to the company, the replay will be posted on the investor relations section of CarisLifeSciences.com for on-demand viewing.

What should shareholders expect from the Caris Life Sciences (CAI) May 7, 2026 call?

Shareholders should expect management discussion of first quarter 2026 financial results during the webcast on May 7, 2026. According to the company, the event will include commentary on results and listening options via live webcast and subsequent replay on the investor site.